CA3256514A1 — Phloroglucinol formulations and methods of use
Assigned to Cinphloro Pharma LLC · Expires 2023-12-21 · 2y expired
What this patent protects
The present disclosure provides pharmaceutical compositions comprising a total amount of about 50 mg to about 1000 mg of an active pharmaceutical ingredient (API) that is phloroglucinol, trimethylphloroglucinol, a pharmaceutically acceptable salt thereof, or a combination thereof…
USPTO Abstract
The present disclosure provides pharmaceutical compositions comprising a total amount of about 50 mg to about 1000 mg of an active pharmaceutical ingredient (API) that is phloroglucinol, trimethylphloroglucinol, a pharmaceutically acceptable salt thereof, or a combination thereof. The pharmaceutical composition comprises an immediate release portion, a first modified release portion, and a second modified release portion. Also provided are oral dosage units comprising the pharmaceutical compositions and methods of treating a spasmodic condition in a subject in need thereof using the pharmaceutical compositions or oral dosage units.
Drugs covered by this patent
Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.
Track this patent
Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.